Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AREA IN-CHF: Canrenone in mild chronic heart failure
NCT00403910Phase 3Completed
- Sponsor
- Heart Care Foundation of India
- Start
- Sep 2002
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of canrenone in heart failure (HF), sponsored by Heart Care Foundation of India. Started Sep 2002; status: completed.
02
Drugs
canrenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00403910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403910.